Diabetes News

Hybrid closed-loop insulin delivery can increase time in range for pregnant women with type 1 diabetes with no safety concerns, according to trial findings presented at the European Association for the Study of Diabetes annual meeting.

The International Working Group on the Diabetic Foot, or IWGDF, recently published updated guidance on the management and prevention of diabetes-related foot diseases.

The HbA1c cutoff for diagnosing women younger than 50 years with diabetes may need to be lower than the cutoff for men, according to study findings.

Metformin may lengthen the time until insulin initiation, lower fasting glucose and improve neonatal outcomes for pregnant women with gestational diabetes, according to data from a randomized trial.

Testosterone therapy may reduce HbA1c for men with type 2 diabetes and hypogonadism, according to a presenter at the European Association for the Study of Diabetes annual meeting.

Exposure to low levels of nuclear radiation may increase the risk for developing diabetes, according to data presented at the European Association for the Study of Diabetes annual meeting.

In the past 2 decades, metformin has become a mainstay of type 2 diabetes management and is now the recommended first-line drug for treating the disease in the United States and worldwide.

Spending more time in natural light may help improve metabolism for adults with type 2 diabetes, according to data from a small study presented at the European Association for the Study of Diabetes annual meeting.

Healio continues its partnership with Cardiometabolic Health Congress in support of the much-anticipated 18th Annual Cardiometabolic Health Congress: Social Determinants and Digital Advances in Cardiorenal Metabolic Health in October.

The FDA has updated the label for Ozempic to include the potential risk for ileus, or an intestinal blockage, as well as increased risk for hypoglycemia if used in combination with insulin or insulin secretagogue.